Drug Profile
Heparin inhalation - Vectura
Alternative Names: VR-496Latest Information Update: 07 Jan 2022
Price :
$50
*
At a glance
- Originator Vectura
- Class Anti-infectives; Anti-inflammatories; Antithrombotics; Bronchodilators; Heparins; Mucolytics
- Mechanism of Action Cell adhesion molecule inhibitors; Heparanase inhibitors; Inflammation mediator inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- No development reported Cystic fibrosis